Total planned funding: $516,396,548
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $112,430,569 |
Nigeria | $105,102,508 |
Zambia | $72,673,944 |
South Africa | $39,583,024 |
Kenya | $29,240,883 |
Vietnam | $19,182,035 |
Ethiopia | $16,702,622 |
Zimbabwe | $13,334,391 |
Burundi | $12,744,136 |
Tanzania | $10,654,708 |
Côte d'Ivoire | $9,510,855 |
India | $8,637,057 |
Malawi | $6,562,109 |
Democratic Republic of the Congo | $6,259,261 |
Botswana | $5,883,389 |
Haiti | $5,586,452 |
Papua New Guinea | $5,486,330 |
Indonesia | $5,126,794 |
Eswatini | $4,397,374 |
Guyana | $4,375,000 |
Uganda | $3,687,400 |
Asia Regional Program | $3,400,093 |
Ghana | $2,750,000 |
Caribbean Region | $2,525,420 |
Angola | $2,466,719 |
South Sudan | $2,266,962 |
Cambodia | $2,025,000 |
Rwanda | $1,687,592 |
Namibia | $1,210,293 |
Lesotho | $653,628 |
Dominican Republic | $250,000 |
Central Asia Region | $0 |
Organizational Types
NGO | $516,396,548 |
Program Areas
Care | $142,652,274 |
Treatment | $131,773,788 |
Prevention | $117,398,370 |
Testing | $37,039,383 |
Governance and Systems | $32,686,733 |
Budget Codes
HTXS: Treatment: Adult Treatment | $115,638,572 |
HKID: Care: Orphans and Vulnerable Children | $81,795,019 |
HVOP: Sexual Prevention: Other Sexual Prevention | $60,996,348 |
HBHC: Care: Adult Care and Support | $40,848,484 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $38,128,263 |
HVCT: Testing: HIV Testing and Counseling | $37,039,383 |
PDTX: Treatment: Pediatric Treatment | $16,135,216 |
OHSS: Health Systems Strengthening | $12,545,116 |
HLAB: Laboratory Infrastructure | $10,941,645 |
PDCS: Care: Pediatric Care and Support | $10,774,402 |
HVTB: Care: TB/HIV | $9,234,369 |
HVSI: Strategic Information | $9,199,972 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,604,404 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $5,053,423 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,704,712 |
HMIN: Biomedical Prevention: Injection Safety | $461,691 |
HMBL: Biomedical Prevention: Blood Safety | $449,529 |
HTXD: Treatment: ARV Drugs | $0 |